"It's easier to take a pill than fix a problem:" qualitative analysis of barriers and facilitators to antimicrobial stewardship program implementation in carceral settings.
Rebecca A Tenner, Emily D Grussing, David Manning, Yvane Ngassa, Jacob J van den Berg, Gabriela Andujar Vazquez, Shira Doron, Maureen Campion, Alysse G Wurcel
{"title":"\"It's easier to take a pill than fix a problem:\" qualitative analysis of barriers and facilitators to antimicrobial stewardship program implementation in carceral settings.","authors":"Rebecca A Tenner, Emily D Grussing, David Manning, Yvane Ngassa, Jacob J van den Berg, Gabriela Andujar Vazquez, Shira Doron, Maureen Campion, Alysse G Wurcel","doi":"10.1186/s44263-024-00090-1","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Widespread antibiotic prescribing contributes to globally emerging antimicrobial resistance (AMR). Despite stewardship recommendations by the Infectious Diseases Society of America, there is a lack of literature identifying barriers and facilitators to antimicrobial stewardship programs (ASPs) in United States (U.S.) carceral settings.</p><p><strong>Methods: </strong>Guided by the Theoretic Domains Framework, we performed in-depth interviews with 68 key stakeholders in Massachusetts carceral settings to contextualize barriers and facilitators to ASP implementation. We recruited 32 people incarcerated in Massachusetts jails and 36 carceral clinicians, correctional officers/administrators in Massachusetts and other U.S. states, and Massachusetts community clinicians for interviews.</p><p><strong>Results: </strong>From the completed semi-structured in-depth interviews, we identified seven salient themes-four barriers and three facilitators-both specific to and across stakeholder groups. Barriers included the following: (1) jail being viewed as a \"dirty place\" that increases the risk of infections; (2) variable awareness and knowledge of AMR and ASPs; (3) clinicians' opposition to change and oversight of their antibiotic prescribing; (4) competing priorities taking precedence over ASP implementation. Facilitators included (5) interest in changing the narrative about carceral healthcare through ASP implementation; (6) opportunities for education about ASP and AMR; and (7) the development of systems, policies, and regulations to improve antibiotic prescribing.</p><p><strong>Conclusions: </strong>To our knowledge, this is the first qualitative study to leverage broad criminal-legal stakeholder groups to inform the next steps in developing and implementing ASPs in carceral settings in the U.S.</p>","PeriodicalId":519903,"journal":{"name":"BMC global and public health","volume":"2 1","pages":"59"},"PeriodicalIF":0.0000,"publicationDate":"2024-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11622897/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC global and public health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s44263-024-00090-1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Widespread antibiotic prescribing contributes to globally emerging antimicrobial resistance (AMR). Despite stewardship recommendations by the Infectious Diseases Society of America, there is a lack of literature identifying barriers and facilitators to antimicrobial stewardship programs (ASPs) in United States (U.S.) carceral settings.
Methods: Guided by the Theoretic Domains Framework, we performed in-depth interviews with 68 key stakeholders in Massachusetts carceral settings to contextualize barriers and facilitators to ASP implementation. We recruited 32 people incarcerated in Massachusetts jails and 36 carceral clinicians, correctional officers/administrators in Massachusetts and other U.S. states, and Massachusetts community clinicians for interviews.
Results: From the completed semi-structured in-depth interviews, we identified seven salient themes-four barriers and three facilitators-both specific to and across stakeholder groups. Barriers included the following: (1) jail being viewed as a "dirty place" that increases the risk of infections; (2) variable awareness and knowledge of AMR and ASPs; (3) clinicians' opposition to change and oversight of their antibiotic prescribing; (4) competing priorities taking precedence over ASP implementation. Facilitators included (5) interest in changing the narrative about carceral healthcare through ASP implementation; (6) opportunities for education about ASP and AMR; and (7) the development of systems, policies, and regulations to improve antibiotic prescribing.
Conclusions: To our knowledge, this is the first qualitative study to leverage broad criminal-legal stakeholder groups to inform the next steps in developing and implementing ASPs in carceral settings in the U.S.
背景:广泛的抗生素处方导致全球出现抗菌素耐药性(AMR)。尽管美国传染病学会(Infectious Diseases Society of America)提出了管理建议,但在美国(U.S.)的医疗环境中,缺乏确定抗菌药物管理计划(asp)的障碍和促进因素的文献。方法:在理论领域框架的指导下,我们对马萨诸塞州的68个关键利益相关者进行了深入访谈,以了解ASP实施的障碍和促进因素。我们招募了32名在马萨诸塞州监狱服刑的人,36名监狱临床医生,马萨诸塞州和美国其他州的惩教官员/行政人员,以及马萨诸塞州的社区临床医生进行访谈。结果:从已完成的半结构化深度访谈中,我们确定了七个突出主题——四个障碍和三个促进因素——分别针对利益相关者群体和跨利益相关者群体。障碍包括:(1)监狱被视为“肮脏的地方”,增加了感染的风险;(2) AMR和asp的变量认知和知识;(3)临床医生反对改变抗生素处方并对其进行监管;(4)竞争优先级优先于ASP实现。促进因素包括(5)有兴趣通过ASP的实施来改变关于医疗保健的叙述;(6) ASP和AMR的教育机会;(7)制定完善抗生素处方的制度、政策和法规。结论:据我们所知,这是第一个利用广泛的刑事法律利益相关者群体的定性研究,为美国监狱环境中发展和实施asp的下一步提供信息